Statement Of Financial Position [Abstract]

Innate Pharma - Filing #2816890

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	—	10 174 EUR	—	—	—	—	—	—	—	—	—	11 694 EUR	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	—	44 192 EUR	—	—	—	—	—	—	—	—	—	46 289 EUR	—	—	—	—	—	—
Deferred tax assets	—	—	—	5 028 EUR	—	—	—	—	—	—	—	—	—	7 087 EUR	—	—	—	—	—	—
Trade and other receivables	—	—	—	48 241 EUR	—	—	—	—	—	—	—	—	—	51 635 EUR	—	—	—	28 716 EUR	—	—
Cash and cash equivalents	—	—	—	103 756 EUR	—	—	—	—	—	—	—	—	—	136 792 EUR	—	—	—	202 887 EUR	—	—
Assets	—	—	—	267 496 EUR	—	—	—	—	—	—	—	—	—	307 423 EUR	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	3 978 EUR	—	—	—	—	—	—	—	—	—	3 950 EUR	—	—	—	—	—	—
Share premium	—	—	—	375 220 EUR	—	—	—	—	—	—	—	—	—	372 131 EUR	—	—	—	—	—	—
Other reserves	—	—	—	456,000 EUR	—	—	—	—	—	—	—	—	—	355,000 EUR	—	—	—	—	—	—
Equity	219 404 EUR	456,000 EUR	1 054 EUR	107 440 EUR	1 054 EUR	52 809 EUR	375 220 EUR	3 978 EUR	156 476 EUR	63 984 EUR	3 950 EUR	355,000 EUR	372 131 EUR	155 976 EUR	472,000 EUR	20 759 EUR	369 617 EUR	217 416 EUR	134 912 EUR	3 941 EUR
Liabilities [abstract]
Trade and other payables	—	—	—	28 573 EUR	—	—	—	—	—	—	—	—	—	29 519 EUR	—	—	—	36 047 EUR	—	—
Deferred tax liabilities	—	—	—	5 028 EUR	—	—	—	—	—	—	—	—	—	7 087 EUR	—	—	—	—	—	—
Equity and liabilities	—	—	—	267 496 EUR	—	—	—	—	—	—	—	—	—	307 423 EUR	—	—	—	—	—	—